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OBJECTIVE
Type 2 diabetes confers a greater excess risk of cardiovascular disease in women
than in men. Diabetes is also a risk factor for dementia, but whether the asso-
ciation is similar in women and men remains unknown. We performed a meta-
analysis of unpublished data to estimate the sex-speciﬁc relationship between
women and men with diabetes with incident dementia.
RESEARCH DESIGN AND METHODS
A systematic search identiﬁed studies published prior to November 2014 that had
reported on the prospective association between diabetes and dementia. Study
authors contributed unpublished sex-speciﬁc relative risks (RRs) and 95% CIs on
the association between diabetes and all dementia and its subtypes. Sex-speciﬁc
RRs and thewomen-to-men ratio of RRs (RRRs) were pooled using random-effects
meta-analyses.
RESULTS
Study-level data from 14 studies, 2,310,330 individuals, and 102,174 dementia
case patients were included. In multiple-adjusted analyses, diabetes was associ-
ated with a 60% increased risk of any dementia in both sexes (women: pooled RR
1.62 [95% CI 1.45–1.80]; men: pooled RR 1.58 [95% CI 1.38–1.81]). The diabetes-
associated RRs for vascular dementia were 2.34 (95% CI 1.86–2.94) in women and
1.73 (95% CI 1.61–1.85) in men, and for nonvascular dementia, the RRs were 1.53
(95% CI 1.35–1.73) in women and 1.49 (95% CI 1.31–1.69) in men. Overall, women
with diabetes had a 19% greater risk for the development of vascular dementia
than men (multiple-adjusted RRR 1.19 [95% CI 1.08–1.30]; P < 0.001).
CONCLUSIONS
Individuals with type 2 diabetes are at ∼60% greater risk for the development of
dementia compared with those without diabetes. For vascular dementia, but not
for nonvascular dementia, the additional risk is greater in women.
Dementia is a multifaceted syndrome that lays claim to a growing burden of global
disease: the most recent estimates suggest that there are ;44 million affected
individuals worldwide and a further 7.7 million new cases annually (1,2). Under-
pinned by a shifting demographic and associated epidemiological proﬁle worldwide,
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the prevalence of dementia is forecast
to nearly double by 2030 and to triple
by 2050 and is set to create a signif-
icant economic, social, and public health
burden particularly in resource-poor
countries (1,2).
Nonvascular dementia, which mainly
constitutes Alzheimer disease (AD), and
vascular dementia are the two most
common forms of dementia, accounting
for ;70% (25 million) and 20% (7 mil-
lion) of all dementia cases, respectively
(2). Lifestyle risk factors, including type 2
diabetes, cigarette smoking, and obesity,
are associated with an increased risk for
the development of both vascular de-
mentia and nonvascular dementia in
later life (3). For example, a review (4)
that included information on ;15,000
cases of dementia found that, compared
with nonaffected individuals, those with
diabetes had an ;70% greater risk for
the development of dementia.
While of value, that review (4) has
some important limitations: .73% of
dementia cases were derived from two
large Asian cohorts (5,6) and the inﬂu-
ence of these studies on the overall
summary estimates was not examined.
Moreover, information on dementia
subtypes was not universally available,
including the single study (5) that pro-
vided information on.50% of all demen-
tia cases. Finally, because the analyses
were not sex speciﬁc, it was not possible
to determine whether the magnitude of
the association between diabetes and in-
cident dementia and its main subtypes
differed in women and men. This is of
interest given the substantial amount
of evidence suggesting that diabetes
confers a signiﬁcantly greater additional
vascular hazard in women compared
with men, which potentially has ramiﬁ-
cations for the clinical management of
diabetes and vascular disease in women
(7–9).
To overcome the substantial method-
ological limitations of past reviews, we
requested individual study investigators
to contribute unpublished results to a
pooled analysis. In line with the current
evidence base, which suggests that di-
abetes poses more of a vascular hazard
in women compared with men, our hy-
pothesis was that diabetes confers a
greater excess risk of vascular dementia
in women than in men, but that the im-
pact of diabetes on the risk for nonvas-
cular dementia is similar between the
sexes.
RESEARCH DESIGN AND METHODS
Search Strategy and Selection Criteria
We used PubMed MEDLINE (www.ncbi
.nlm.nih.gov) and Ovid MEDLINE for the
period from January 2011 to November
2014 to identify studies that had report-
ed on the association between diabetes
and dementia in men and women
from a general population. The search
strategy combined the following text
and MeSH terms: “dementia,” “vascular
dementia,” “delirium,” “cognitive dis-
orders,” “amnestic disorders,” “fronto-
temporal dementia,” “multi-infarct
dementia,” “Alzheimer disease,” “Lewy
body,” “type 2 diabetes mellitus,”
“diabetes mellitus,” “DM,” “diabetes
complications,” “blood glucose,” “im-
paired glucose tolerance,” “glycosylated
hemoglobin,” and “prediabetes.” Studies
prior to 2011 were identiﬁed from previ-
ous systematic reviews (4,10,11). Data
from randomized trials were excluded
because of the nongeneralizable nature
of trials to the general population. Two
authors (S.C. and S.A.E.P.) conducted the
literature search. Uncertainties regard-
ing the identiﬁcation of studies were dis-
cussed and resolved by mutual consent.
Because most studies did not publish es-
timates of relative risk (RR) separately
for men and women or for dementia
subtypes and varied by which factors
were included in adjusted models, we
contacted the authors of all of the se-
lected studies and asked them to provide
additional results adjusted,wherepossible,
for the same set of confounders: blood
pressure, cigarette smoking, BMI, and
total cholesterol level. On a speciﬁcally
designed form, contributing authors
provided summary results for the age-
adjusted and multiple-adjusted RRs and
95% CIs for any dementia and, if avail-
able, for vascular dementia and nonvas-
cular dementia segregated by sex.
Data Extraction and Statistical
Analysis
The primary end points were incident
all-cause dementia, vascular dementia,
and nonvascular dementia (as deﬁned
by the study investigators; see Sup-
plementary Table 1). The primary metrics
were the pooled multiple-adjusted RRs
for dementia associated with diabetes
and the women-to-men ratio of the RRs
(RRR). Covariates that were included in
themultiple-adjustedmodelwere report-
ed differently between studies and are
shown in Table 1. Age-adjusted estimates
were used in a secondary analysis. From
each study, we obtained the previously
unpublished sex-speciﬁc RRs with accom-
panying 95% CIs for individuals with ver-
sus without diabetes. We also requested
information on the number of person-
years of follow-up to calculate sex-speciﬁc
incidence rates in individuals with and
without diabetes. We log transformed
these RRs and pooled them across studies
using random-effects meta-analysis with
inverse variance weighting and then ex-
ponentiated these values to obtain the
pooled RR separately for women and
men. We used similar methods to pool
women-to-men RRRs. For each study,
we obtained the SE of the log RRR by tak-
ing the square root of the sum of the var-
iance of the two sex-speciﬁc log RRs. We
used the I2 statistic to estimate the per-
centage of variability across studies due to
between-study heterogeneity. In sensitiv-
ity analyses, we excluded estimates from
two large cohort studies (6,12) fromTaiwan
and Korea that had a large inﬂuence on
the summary estimates.Wealso examined
whether restricting the analysis to those
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studies that used higher-quality research
criteria for dementia diagnosis (e.g., the
Cross-Cultural Cognitive Examination
and National Institute of Neurological and
Communicative Disorders and Stroke and
the Alzheimer’s Disease and Related Dis-
orders Association Alzheimer’s criteria)
affected the main results. We explored
whether the background rate of demen-
tia in the study population inﬂuenced
the sex-speciﬁc associations by meta-
regression analyses of the log RRR versus
the difference in incidence rate between
womenwith andwithout diabetesminus
the equivalent estimate in men (i.e., the
difference of the difference). We as-
sessed the methodological quality of
the studies using the Newcastle-Ottawa
Scale (Supplementary Data) (13). All
analyses were performed using Stata
version 12.0.
RESULTS
The systematic search identiﬁed 1,495
unique articles that were subsequently
examined on title and abstract (Sup-
plementary Fig. 1). Overall, 1,425 arti-
cles were excluded for one or more
reasons including lack of primary data,
single-sex population, animal study,
non-prospective study design, and ran-
domized trial of a high-risk population.
Of the remaining articles, 70 articles
qualiﬁed for full-text evaluation. Of
these, 28 studies had relevant data on
the relationship between diabetes and
risk of dementia, and the authors were
contacted and asked to contribute addi-
tional estimates to those in the pub-
lished reports. Authors from 13 studies
(response 48%) contributed unpub-
lished summary data (12,14–25), and
for 1 study (6) we extracted the neces-
sary data from its published report. The
14 noncontributing studies comprised
30,900 individuals and 2,300 cases of
dementia (Supplementary References),
and the baseline characteristics are de-
scribed in Table 1. Overall, data were
available on 2,310,330 individuals (48%
women) and 102,174 incident cases of
dementia, including 9,253 cases of vascu-
lar dementia (52% women) and 90,233
cases of nonvascular dementia (58%
women). Three cohorts were from Asia
(90% of the individuals) (6,12,23), four
were from Europe (9%) (16,19,24,25),
and seven were from the Americas (1%)
(14,15,17,18,20–22). The mean age of
study participants ranged from 43 to
83 years, and the mean study duration
ranged from 2 to 35 years across studies.
The included studies were generally of
good tovery goodquality (Supplementary
Table 1). There was variation in the inci-
dence rates for dementia among popula-
tions (Supplementary Table 2).
Compared with not having diabetes,
diabetes was signiﬁcantly associated
with;60% increased risk of any demen-
tia in both sexes; the multiple-adjusted
pooled RR for any dementia associated
with diabetes was 1.68 (95% CI 1.64–
1.71) in women and 1.61 (95% CI 1.42–
1.83) in men (Figs. 1 and 2). There was
moderate heterogeneity between stud-
ies in both women (I2 = 40%, P = 0.065)
andmen (I2 = 48%, P = 0.048). The size of
the associations in women and men re-
mained robust after excluding data, in
turn, from the two large Asian cohorts
(Supplementary Fig. 2). Results from the
age-adjusted analyses were not materi-
ally different (RR 1.58 [95% CI 1.41–
1.78] in women, RR 1.65 [95% CI 1.46–
1.87] in men). Restricting the analysis to
studies that used higher-quality research
criteria to diagnose dementia had little
effect on the summary estimates (RR
1.65 [95% CI 1.42–1.91] in women, RR
1.49 [95% CI 1.19–1.87] in men).
Diabetes was associated with a sig-
niﬁcantly increased risk of vascular de-
mentia in both women and men; the
multiple-adjusted pooled RR was 2.34
(95% CI 1.86–2.94) in women and 1.73
(95% CI 1.61–1.85) in men (Figs. 1 and
2). Between-study heterogeneity was
moderate for women (I2 = 34%, P =
0.14) and was absent for men (I2 = 0%,
P = 0.86). Excluding data from either of
the large Asian cohorts had no discernible
impact on the results (Supplementary Fig.
2). The age-adjusted estimates were 2.23
(95% CI 1.72–2.90) in women and 2.02
(95% CI 1.90–2.16) in men. The summary
estimates from those studies that used
the higher-quality research criteria for
the diagnosis of dementia did not differ
appreciably from the multiple-adjusted
estimates (2.43 [95% CI 1.67–3.54] and
1.86 [95% CI 1.25–2.76]).
Individuals with diabetes also had a
50% increased risk for the development
of nonvascular dementia compared
with unaffected people: the multiple-
adjusted pooled RR was 1.53 (95% CI
1.35–1.73) in women and 1.49 (95% CI
1.31–1.69) in men (Figs. 1 and 2).
Between-study heterogeneity was low-
moderate in both sexes (I2 = 30%, P =
0.16 in women; 19%, P = 0.27 in men).
These estimates were largely unaffected
after the exclusion of data from the two
largest studies (Supplementary Fig. 2).
The age-adjusted estimates were
weaker in both women and men (1.44
[95% CI 1.26–1.65] and 1.34 [95% CI
1.05–1.70], respectively). Restricting
the search to studies that used research
criteria for the diagnosis of dementia did
not materially affect the summary esti-
mates (1.47 [95% CI 1.20–1.81] in
women and 1.34 [95% CI 0.99–1.80] in
men).
Diabetes conferred a signiﬁcantly
greater excess risk for the development
of dementia in women, but this was con-
ﬁned to vascular dementia (Fig. 3).
Women with diabetes had a 19% (95%
CI 8–30%, P, 0.001) greater excess risk
for vascular dementia compared with
men with diabetes, with no evidence
of signiﬁcant between-study heteroge-
neity (I2 =0%, P = 0.58). This effect re-
mained following the exclusion of data
from the Korean study (RRR 1.18 [95% CI
1.07–1.30]) (6) and the Taiwanese study
(12), although it was then no longer sta-
tistically signiﬁcant (RRR 1.33 [95% CI
0.94–1.88]) (Supplementary Fig. 2). In
the age-adjusted analysis, there was no
signiﬁcant sex difference in the associa-
tion between diabetes and vascular de-
mentia (RRR 1.10 [95% CI 0.84–1.45], P =
0.49). For nonvascular dementia, there
was no evidence of a sex difference in
the effect of diabetes from either the
multiple-adjusted estimate (Fig. 3) or
the age-adjusted estimate (RRR 1.05
[95% CI 0.81–1.36]). The results did not
change appreciably after excluding data
from the Taiwanese (12) or Korean (6)
studies (Supplementary Fig. 2). Restrict-
ing the analysis to those studies that
used the research criteria for the diag-
nosis of dementia produced a similar
pattern of results, although the sex dif-
ference with vascular dementia was no
longer statistically signiﬁcant (RRR 1.24
[95% CI 0.73–2.11]).
Given the substantial variation in
background rates of dementia and its
major subtypes across the studies, we
examined what impact such heteroge-
neity may have had on the RRR estimate
through meta-regression analysis. The
overall estimate of the RRR was robust
to between-study differences in diabe-
tes incident rates because there was no
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signiﬁcant evidence that differences in
background rates materially inﬂuenced
the RRR estimate for either vascular de-
mentia (Pfor heterogeneity = 0.22) or nonvas-
cular dementia (Pfor heterogeneity = 0.30)
CONCLUSIONS
This pooled analysis of 14 studies com-
bined largely unpublished data from
.2.3 million individuals and informa-
tion on .102,000 incident cases of
dementiadmore than seven times the
amount of information as in previous
reviews of the same topic (4,10,11).
Our ﬁndings offer support for a role of
diabetes in the etiology of dementia,
although the magnitude of the relation-
ship differs according to subtype over-
all, diabetes was associated with an
;60% increased risk of all-cause de-
mentia and a 40% risk of nonvascular
dementia in both women and men, in-
dependent of important confounders.
For vascular dementia, the association
was stronger, with evidence of a stronger
effect in women than in men. Compared
with people with no diabetes, after
adjusting for possible confounders,
womenwith diabetes had a 120% greater
risk for the development of vascular de-
mentia compared with a 70% greater risk
in men, which equated to an 18% signif-
icantly greater excess risk in women with
diabetes compared with similarly af-
fected men. These results were largely
robust to the exclusion of data from two
large cohorts that together comprised
96% of all incident cases of dementia
(6,12).
The recorded excess RR of vascular
dementia in womenmight be an artifact
of the data driven by higher absolute
rates for incident dementia in men
than in women in the background pop-
ulation. If this were true, then the rela-
tive effect of diabetes on incident
dementia would be greater in women
than in men in populations in which
the absolute incident rate is higher in
men than in women, but should con-
verge when the rates are similar be-
tween the sexes. However, our present
ﬁndings show evidence to the contrary,
with a trend toward higher incident rate
ratios (indicating a greater excess risk in
women than in men) in studies in which
the background incident rates for demen-
tia were higher in women than in men.
Previous reviews (4,10,11) of the as-
sociation between diabetes and risk of
dementia reported slightly larger esti-
mates, but were still compatible with
those presented here. Moreover, be-
cause these reviews were reliant on
published data, they were largely un-
able to examine the effect of diabetes
on dementia subtypes and the impact of
confounding or to perform sex-speciﬁc
comparisons. In contrast, by sourcing
previously unpublished study-level esti-
mates, we were largely able to over-
come these limitations. Moreover, by
standardizing the level of adjustment
for other major vascular risk factors
across studies (as far as possible), we
not only lessened the possible effect of
residual confounding on study estimates,
but we could also examine whether ad-
justment had a similar effect on the age-
adjusted estimates for women and men.
Our ﬁndings indicated that adjustment
Figure 1—Multiple-adjusted RR for any dementia, vascular dementia, and nonvascular dementia in women, comparing individuals with diabetes to
those without diabetes. Horizontal bars represent 95% CIs.
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for other vascular risk factors on the as-
sociation between diabetes and risk of
vascular dementia had opposing effects
in women and men: in women, adjust-
ment tended to strengthen theassociation
(by;7%), whereas inmen the association
was somewhat weakened (by 14%), which
would explain the lack of an observed
sex difference in the risk of diabetes for
Figure 3—Multiple-adjustedwomen-to-men RRRs for any dementia, vascular dementia, and nonvascular dementia, comparing individuals with diabetes
to those without diabetes. Horizontal bars represent 95% CIs.
Figure 2—Multiple-adjusted RR for any dementia, vascular dementia, and nonvascular dementia in men, comparing individuals with diabetes to
those without diabetes. Horizontal bars represent 95% CIs.
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vascular dementia in the age-adjusted
estimate.
Whereas several processes are thought
to promote the onset of dementia in in-
dividuals with diabetes, the biological ba-
sis of this relationship is still uncertain.
Findings from a recent study (26) that
examined the genetic susceptibility to
type 2 diabetes and risk of late-onset
AD have shown that genotype risk scores
for diabetes were not associated with in-
creased risk of late-onset AD. Therefore,
even though we attempted to control for
confounding, it is probable that the ob-
served association between diabetes and
nonvascular dementia is noncausal and
possibly is driven by other disease pro-
cesses or known (and unknown) risk fac-
tors that are common to both diabetes
and nonvascular dementia. But, both
the size of the association and the fact
that diabetes is a known risk factor for
microvascular and macrovascular compli-
cations, including coronary heart disease
and stroke, would suggest that the rela-
tionship between diabetes and vascular
dementia is robust and not solely driven
by confounding.
Studies in support of a biological re-
lationship between diabetes and vascu-
lar and nonvascular dementia suggest a
multifactorial pathogenesis involving
insulin metabolism, hyperglycemic tox-
icity, chronic inﬂammatory processes,
and vascular changes (27,28). Insulin re-
sistance is thought to promote athero-
sclerosis, to change cerebral energy
metabolism, and to lead to vascular-
related cognitive impairment and de-
mentia (27). Oxidative stress due to
chronic hyperglycemia can also lead
to vascular changes in the nervous sys-
tem and an accumulation of advanced
glycation end products that are found
in AD (28). Conversely, severe hypogly-
cemia, which in most cases is driven by
insulin or sulfonylurea treatment of di-
abetes, is associated with cognitive im-
pairment by precipitating neuronal
death and increased production of co-
agulation factors (27). Type 2 diabetes
is also associated with an increased ex-
pression of interleukin-6 in the central
nervous system, causing inﬂammation
of the brain and, in conjunction with
oxidative stress, is implicated in the
pathogenesis of AD (27). Two prospec-
tive neuropathological cohort studies
(28,29) suggested that diabetes may
lower the threshold for the amount
of amyloid required for the development
of AD by inducing adverse microvascular
changesdsmall-vessel infarctsdin the
brain. There is now growing evidence to
suggest that dementia subtypes aremore
heterogeneous pathologically than previ-
ously thought and that underlying vascu-
lar changes play a role in both vascular
and nonvascular dementia (3).
The present analyses provide further
support for the hypothesis that the ad-
verse consequences of diabetes on vas-
cular risk are stronger in women than in
men (7–9). Although a sex disparity in
the management and treatment of dia-
betes, most often to the detriment of
women, may be involved, accruing evi-
dence suggests that real biological dif-
ferences between women and men
underpin the excess risk of diabetes-
related vascular risk in women. For
example, exposure to endogenous es-
tradiol in women may also play a
role; a recent study (30) among post-
menopausal women found that higher
levels of endogenous estradiol, especially
in women with diabetes, conferred a
greater risk of dementia. There is also
some evidence from autopsy studies to
suggest that the greater diabetes-related
excess risk of vascular dementia observed
in women may be mediated by greater
neurological microvascular damage: on the
basis of neuropathological assessment,
the Adult Changes in Thought (ACT) Study
reported two patterns of cerebral injury
associated with dementia in individuals
with and without diabetes. In those indi-
viduals without diabetes, dementia was
associatedwith higher amyloid B peptide,
whereas in individuals with diabetes,
dementia was characterized by greater
microvascular infarcts and neuroinﬂam-
mation (Supplementary Reference 15).
However, whether the latter was more
pronounced in women than in men was
not examined and requires further inves-
tigation by future studies that are ade-
quately powered to detect sex differences.
Limitations of our study include the
differences across studies in study de-
sign and duration, end point deﬁnition,
and ascertainment of diabetes (which
was either measured or based on self-
report depending on the study). We
were also unable to include data from
14 eligible cohorts with 2,300 incident
cases of dementia. However, given
that the current analyses are based on
.100,000 incident cases, it is unlikely
that their omission had a profound im-
pact on the results. It should be noted,
however, that .96% of the cases were
derived from two large studies; reassur-
ingly, however, the exclusion of either
study did not materially alter the pat-
tern of the results (although in some
instances the associations were not sta-
tistically signiﬁcant). It should be noted,
however, that the heterogeneity in the
method of diagnosis of dementia and its
subtypes is a signiﬁcant (and unquantiﬁ-
able) limitation of this analysis. For ex-
ample, ascertainment of dementia from
the two large Asian cohorts was reliant
on diagnoses obtained from administra-
tive databases that may be particularly
susceptible to detection bias or case re-
porting (Supplementary Reference 16),
whereas in other, much smaller studies, a
diagnosis of dementia was based on clin-
ical examination by two ormore clinicians
(25). We also did not examine the associ-
ation between duration of diabetes or
glycemic control and the risk for demen-
tia, nor did we evaluate the association
between diabetes and cognitive function-
ing. The diagnosis of vascular dementia in
epidemiological studies, and its overlap
with AD and other forms of dementia,
without neuropathological validation is
also a signiﬁcant limitation and may
have overestimated the impact of diabe-
tes for dementia subtypes.Whilewe used
accepted criteria to distinguish between
AD and vascular dementia, there is in-
creasing recognition that dementia has a
mixed pathophysiology (Supplementary
References 17 and 18). At present, no
standardized thresholds by which to cate-
gorize mixed dementia exist andwere not
examined within the individual studies;
hence, we were unable to examine sex
differences in the diabetes-related risk of
mixed dementia. Misclassiﬁcation of de-
mentia status, which may have occurred
differentially in women and men, will
have introduced bias, the extent (and di-
rection) of which remains unknown. We
also did not have information on the du-
ration of diabetes status and level of gly-
cemic control, either of which may have
signiﬁcantly interacted with risk of de-
mentia (either to a similar or different ex-
tent in women and men).
Future prospective studies, with exten-
sive phenotypic and genetic data on risk
factors common to both diabetes and
subtypes of dementia, are needed to ex-
amine whether these relationships are
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causal. Moreover, our ﬁnding of a greater
diabetes-related risk of vascular demen-
tia in women than in men contributes to
the growing evidence base that diabetes
confers a proportionally greater vascular
hazard in women than in men.
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